Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer

F Wu, J Yang, J Liu, Y Wang, J Mu, Q Zeng… - … and Targeted Therapy, 2021 - nature.com
To flourish, cancers greatly depend on their surrounding tumor microenvironment (TME),
and cancer-associated fibroblasts (CAFs) in TME are critical for cancer occurrence and …

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy

T Liu, C Han, S Wang, P Fang, Z Ma, L Xu… - Journal of hematology & …, 2019 - Springer
Among all the stromal cells that present in the tumor microenvironment, cancer-associated
fibroblasts (CAFs) are one of the most abundant and critical components of the tumor …

Role of cancer‐associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer

R Mhaidly, F Mechta‐Grigoriou - Immunological reviews, 2021 - Wiley Online Library
The tumor microenvironment (TME) has been identified as one of the driving factors of tumor
progression and invasion. Within this microenvironment, cancer‐associated fibroblasts …

Multispecific drugs herald a new era of biopharmaceutical innovation

RJ Deshaies - Nature, 2020 - nature.com
The modern biopharmaceutical industry traces its roots to the dawn of the twentieth century,
coincident with marketing of aspirin—a signature event in the history of modern drug …

Immune cells and immunotherapy for cardiac injury and repair

JG Rurik, H Aghajanian, JA Epstein - Circulation research, 2021 - Am Heart Assoc
Cardiac injury remains a major cause of morbidity and mortality worldwide. Despite
significant advances, a full understanding of why the heart fails to fully recover function after …

Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities

D Hu, Z Li, B Zheng, X Lin, Y Pan, P Gong… - Cancer …, 2022 - Wiley Online Library
The tumor microenvironment is proposed to contribute substantially to the progression of
cancers, including breast cancer. Cancer‐associated fibroblasts (CAFs) are the most …

Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways

Z Zhu, AJR McGray, W Jiang, B Lu, P Kalinski, ZS Guo - Molecular cancer, 2022 - Springer
Oncolytic viruses (OVs) represent a new class of multi-modal immunotherapies for cancer,
with OV-elicited antitumor immunity being key to their overall therapeutic efficacy. Currently …

[HTML][HTML] Cancer-associated fibroblast (CAF) heterogeneity and targeting therapy of CAFs in pancreatic cancer

X Geng, H Chen, L Zhao, J Hu, W Yang, G Li… - Frontiers in cell and …, 2021 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease that typically features a
dramatic desmoplastic reaction, especially fibroblasts. The roles of cancer-associated …

Oncolytic viruses for cancer therapy: barriers and recent advances

M Zheng, J Huang, A Tong, H Yang - Molecular Therapy-Oncolytics, 2019 - cell.com
Oncolytic viruses (OVs) are powerful new therapeutic agents in cancer therapy. With the first
OV (talimogene laherparepvec [T-vec]) obtaining US Food and Drug Administration …

Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures

B Feng, J Wu, B Shen, F Jiang, J Feng - Cancer Cell International, 2022 - Springer
Cancer-associated fibroblasts (CAFs) are critical components of the tumor microenvironment
(TME) with diverse functions such as extracellular matrix (ECM) remodeling, modulation of …